Parecoxib as an Alternative in COX-2 Hypersensitivity

The group of non-steroidal anti-inflammatory drugs (NSAIDs) is commonly involved in hypersensitivity reactions. In clinical practice the physician is often faced with the need to choose an alternative anti-inflammatory agent for a patient who has suffered a hypersensitivity reaction to a NSAID. The...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of immunopathology and pharmacology Vol. 21; no. 1; pp. 233 - 235
Main Authors Colanardi, M.C., Nettis, E., Traetta, P., Delle Donne, P., Ferrannini, A., Vacca, A.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The group of non-steroidal anti-inflammatory drugs (NSAIDs) is commonly involved in hypersensitivity reactions. In clinical practice the physician is often faced with the need to choose an alternative anti-inflammatory agent for a patient who has suffered a hypersensitivity reaction to a NSAID. The most common approach to choosing the safest NSAID is to perform a challenge test. Parecoxib is the first injectable COX-2 selective inhibitor indicated for the treatment of acute postoperative pain. The authors report the case of a patient with a history of cutaneous adverse reactions to different classes of NSAIDs, including selective COX-2 inhibitors, who underwent and tolerated challenge with parecoxib.
ISSN:0394-6320
2058-7384
DOI:10.1177/039463200802100127